Scott Power

Morgans Financial Ltd.

Image: Scott Power

Scott Power has spent the last 20 years investing in and researching emerging companies. His first role in the venture capital industry was with QIDC. He joined Morgans Financial Ltd. in 1997. Power sees Australia as a country that produces world-class technology, particularly in the life science sector. Companies like Cochlear Ltd., CSL Ltd. and Resmed have established themselves as market leaders, and a number of up-and-coming companies across the healthcare, life science and technology sectors are poised to follow the leaders, potentially generating significant profits. Power has a wide network of contacts across these sectors that help him identify key trends and developments. Power holds a bachelor's degree in commerce from the University of Queensland and a graduate diploma in applied finance from FINSIA. He is a certified practicing accountant (CPA).

Recent Quotes

"IPD posted a solid Q3 FY15 as it rolls out its technology."

— Scott Power, Morgans Financial Ltd. (4/15/15)
more >

"IPD is one of our High Conviction calls for 2015."

— Scott Power, Morgans Financial Ltd. (2/25/15)
more >

"IPD remains one of our High Conviction calls."

— Scott Power, Morgans Financial Ltd. (2/4/15)
more >

"We like IPD, which has an early detection device for lymphedema."

The Life Sciences Report Interview with Scott Power (10/2/14)
more >

"IPD has had a transformational event; we increase our price target for the company."

— Scott Power, Morgans (9/5/14)
more >

"ACL enrolled its first patient in CHIME, which is positive news."

— Scott Power, Morgans Financial Ltd. (6/19/14)
more >

"ACL's Phase 3 trial results will be released before Q3/14E."

— Scott Power, Morgans Financial Ltd. (6/12/14)
more >

"With any success in this clinical trial—which is what we're expecting—ACL will be in a position to possibly license HA-irinotecan out."

The Life Sciences Report Interview with Scott Powers (4/17/14)
more >



Due to permission requirements, not all quotes are shown.